Standard treatment-refractory/ineligible small cell lung cancer treated with drug-eluting beads bronchial arterial chemoembolization: a retrospective cohort study.

Xu, Sheng; Li, Yuan-Ming; Bie, Zhi-Xin; Li, Xiao-Guang

Xu, Sheng; Li, Yuan-Ming; Bie, Zhi-Xin; Li, Xiao-Guang.

Afiliación

Xu S; Department of Minimally Invasive Tumor Therapies Center, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Li YM; Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
Bie ZX; Department of Minimally Invasive Tumor Therapies Center, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Li XG; Department of Minimally Invasive Tumor Therapies Center, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.

Quant Imaging Med Surg ; 13(1): 339-351, 2023 Jan 01.

Article en En | MEDLINE | ID: mdl-36620174

Palabras clave

Small cell lung cancer (SCLC); anlotinib; chemoembolization; drug-eluting beads (DEBs); survival

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Quant Imaging Med Surg Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google